Melioidosis
What's New
Last Posted: Mar 15, 2023
- Phenotypic and genetic alterations of Burkholderia pseudomallei in patients during relapse and persistent infections.
Seng Rathanin, et al. Frontiers in microbiology 2023 0 1103297 - Flagellin-independent effects of a Toll-like receptor 5 polymorphism in the inflammatory response to Burkholderia pseudomallei.
Dickey Amy K, et al. PLoS neglected tropical diseases 2019 0 (5) e0007354 - A nonsense mutation in TLR5 is associated with survival and reduced IL-10 and TNF-a levels in human melioidosis.
Chaichana Panjaporn, et al. PLoS neglected tropical diseases 2017 5 (5) e0005587 - Exonic sequencing identifies TLR1 genetic variation associated with mortality in Thais with melioidosis.
Wright Shelton W, et al. Emerging microbes & infections 2019 0 (1) 282-290 - Identification of CD4+ T-cell epitope and investigation of HLA distribution for the immunogenic proteins of Burkholderia pseudomallei using in silico approaches - A key vaccine development strategy for melioidosis.
Swetha Rayapadi G, et al. Journal of theoretical biology 2016 4 11-18 - Use of Whole-Genome Sequencing to Link Burkholderia pseudomallei from Air Sampling to Mediastinal Melioidosis, Australia.
Currie Bart J et al. Emerging infectious diseases 2015 Nov (11) 2052-4 - Common TLR1 genetic variation is not associated with death from melioidosis, a common cause of sepsis in rural Thailand.
Chantratita Narisara, et al. PloS one 2014 0 (1) e83285 - Screen of whole blood responses to flagellin identifies TLR5 variation associated with outcome in melioidosis.
Chantratita N, et al. Genes and immunity 2014 3 (2) 63-71 - The role of NOD2 in murine and human melioidosis.
Myers ND, et al. Journal of immunology (Baltimore, Md. : 1950) 2013 12 - Impaired TLR5 functionality is associated with survival in melioidosis.
West T Eoin, et al. Journal of immunology (Baltimore, Md. : 1950) 2013 4 (7) 3373-9
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: